The 2010 ACR/EULAR RA classification applies to patients with:
- At least 1 joint with definite clinical synovitis (swelling)
- Synovitis not better explained by another disease
- Select the patient's joint involvement pattern (Domain A).
- Select the serology result (RF and/or anti-CCP/ACPA) (Domain B).
- Select the acute-phase reactant status (CRP and ESR) (Domain C).
- Select the duration of symptoms (Domain D).
- Score ≥6/10 = "definite RA" for classification purposes. Result updates automatically.
All computation runs in your browser; no values are stored or transmitted.
When to Use
Appropriate population
Patients with new inflammatory arthritis to classify RA for early treatment. Use to distinguish RA from other inflammatory arthropathies (psoriatic, reactive, crystal, septic).
CKD consideration
RA is associated with secondary AA amyloidosis causing renal disease. NSAIDs should be avoided in CKD Stage 3 or higher (eGFR <60). Monitor renal function in all RA patients at baseline and on DMARD therapy.
Pearls & Pitfalls
Classification vs. diagnosis
These are classification criteria (for research), not diagnostic criteria — clinical judgment remains essential. High anti-CCP antibodies are more specific for RA than RF (~95% specific).
Seronegative RA
Seronegative RA (no RF/ACPA) scores ≤1 in the serology domain — joint involvement and duration scores become more important for reaching the ≥6 threshold.
Renal safety of RA drugs
- NSAIDs: common trigger for AKI and CKD progression — avoid if eGFR <60
- Methotrexate: renal dose adjustment required; avoid if eGFR <30; folic acid supplementation mandatory
- Hydroxychloroquine: generally safe in CKD; no dose adjustment typically needed
- Sulfasalazine: avoid in severe CKD
Why Use It
Early RA classification enables timely DMARD initiation, which prevents joint destruction and systemic complications including AA amyloidosis-related nephropathy. The 2010 criteria replaced the 1987 ACR criteria with improved sensitivity for early disease — joints, serology, acute-phase reactants, and symptom duration are each independently weighted, allowing classification even before classic radiographic erosions appear.
2010 ACR/EULAR RA Classification Criteria
Select findings in each domain. Maximum total score is 10. Score ≥6 classifies as definite RA.
The 2010 ACR/EULAR criteria are classification criteria, not diagnostic criteria. A score ≥6 supports RA classification but does not replace clinical examination and rheumatologist assessment. For educational reference only. Reference: Aletaha D et al., Arthritis Rheum 2010.
Next Steps
Use the classification score to guide referral and management.
- Score ≥6 (Definite RA): Refer to rheumatology for early DMARD initiation (methotrexate first-line). Avoid NSAIDs if eGFR <60. Obtain baseline eGFR and CBC before starting methotrexate.
- Score 5 (Possible Early RA): Rheumatology referral for reassessment at 6 weeks; repeat serology; consider MRI or musculoskeletal ultrasound for synovitis confirmation.
- Score <5 (Criteria Not Met): Consider other inflammatory arthropathies (psoriatic, reactive, crystal, septic). Reassess if symptoms persist or worsen.
- All RA patients: Avoid NSAIDs if eGFR <60; monitor eGFR at baseline and periodically on DMARD therapy; screen for AA amyloidosis if longstanding active disease with proteinuria.
Evidence & References
Scoring Domains
| Domain | Finding | Points |
|---|---|---|
| A — Joint Involvement | 1 large joint | 0 |
| 2–10 large joints | 1 | |
| 1–3 small joints (with or without large) | 2 | |
| 4–10 small joints (with or without large) | 3 | |
| >10 joints (at least 1 small joint) | 5 | |
| B — Serology | Negative RF AND negative ACPA | 0 |
| Low positive RF or low positive ACPA (≤3× ULN) | 2 | |
| High positive RF or high positive ACPA (>3× ULN) | 3 | |
| C — Acute-Phase Reactants | Normal CRP AND normal ESR | 0 |
| Abnormal CRP OR abnormal ESR | 1 | |
| D — Duration of Symptoms | <6 weeks | 0 |
| ≥6 weeks | 1 |
Maximum score: 10. Score ≥6 = definite RA. Large joints: shoulders, elbows, hips, knees, ankles. Small joints: MCP, PIP, 2nd–5th MTP, thumb IP, wrist. Excludes DIP joints, first CMC joints, first MTP joints.
References
- Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid Arthritis Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum. 2010;62(9):2569–2581.
- Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2016;68(1):1–26.
